This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Jan 1;399(10319):24.

doi: 10.1016/S0140-6736(21)02732-X.

New INN nomenclature for monoclonal antibodies

Raffaella Balocco¹, Sofia De Sousa Guimaraes Koch², Robin Thorpe³, Karin Weisser⁴, Sarel Malan⁵

Affiliations

Affiliations

¹ INN Unit, WHO, Geneva, CH-1211, Switzerland. Electronic address: baloccor@who.int.
² INN Unit, WHO, Geneva, CH-1211, Switzerland.
³ Welwyn, UK.
⁴ Paul Erlich Institute, Langen, Germany.
⁵ School of Pharmacy, University of the Western Cape, Cape Town, South Africa.

PMID: 34973717
DOI: 10.1016/S0140-6736(21)02732-X

Comment

New INN nomenclature for monoclonal antibodies

Raffaella Balocco et al. Lancet. 2022.

. 2022 Jan 1;399(10319):24.

doi: 10.1016/S0140-6736(21)02732-X.

Authors

Raffaella Balocco¹, Sofia De Sousa Guimaraes Koch², Robin Thorpe³, Karin Weisser⁴, Sarel Malan⁵

Affiliations

¹ INN Unit, WHO, Geneva, CH-1211, Switzerland. Electronic address: baloccor@who.int.
² INN Unit, WHO, Geneva, CH-1211, Switzerland.
³ Welwyn, UK.
⁴ Paul Erlich Institute, Langen, Germany.
⁵ School of Pharmacy, University of the Western Cape, Cape Town, South Africa.

PMID: 34973717
DOI: 10.1016/S0140-6736(21)02732-X

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

The INN global nomenclature of biological medicines: A continuous challenge.
Robertson JS, Chui WK, Genazzani AA, Malan SF, López de la Rica Manjavacas A, Mignot G, Thorpe R, Balocco R, Rizzi M. Robertson JS, et al. Biologicals. 2019 Jul;60:15-23. doi: 10.1016/j.biologicals.2019.05.006. Epub 2019 May 23. Biologicals. 2019. PMID: 31130314 Review.

Similar articles

No new 'mabs' in medicine-New nomenclature for monoclonal antibodies.
Lythgoe MP. Lythgoe MP. Br J Pharmacol. 2022 Dec;179(24):5338-5339. doi: 10.1111/bph.15953. Epub 2022 Sep 27. Br J Pharmacol. 2022. PMID: 36167063 No abstract available.
International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
Guimaraes Koch SS, Thorpe R, Kawasaki N, Lefranc MP, Malan S, Martin ACR, Mignot G, Plückthun A, Rizzi M, Shubat S, Weisser K, Balocco R. Guimaraes Koch SS, et al. MAbs. 2022 Jan-Dec;14(1):2075078. doi: 10.1080/19420862.2022.2075078. MAbs. 2022. PMID: 35584276 Free PMC article.
[Monoclonal antibodies].
Mössner J, Neubauer A. Mössner J, et al. Internist (Berl). 2019 Oct;60(10):1009-1013. doi: 10.1007/s00108-019-00680-4. Internist (Berl). 2019. PMID: 31560084 German. No abstract available.
[Evolution of monoclonal antibodies in cancer treatment].
Kubczak M, Rogalińska M. Kubczak M, et al. Postepy Biochem. 2016;62(4):518-525. Postepy Biochem. 2016. PMID: 28132454 Review. Polish.
[Therapeutic regimens using monoclonal antibodies in gastroenterology].
Dobsch P, Michels B, Müller-Schilling M, Kandulski A. Dobsch P, et al. Internist (Berl). 2019 Oct;60(10):1043-1058. doi: 10.1007/s00108-019-00682-2. Internist (Berl). 2019. PMID: 31501913 Review. German.

See all similar articles

Cited by

Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer.
Bose CK, Basu N. Bose CK, et al. J Gynecol Oncol. 2024 Jul;35(4):e82. doi: 10.3802/jgo.2024.35.e82. Epub 2024 May 17. J Gynecol Oncol. 2024. PMID: 38789395 Free PMC article. Review.
Utilizing Biologics in Drug Desensitization.
Yang BC, Castells MC. Yang BC, et al. Curr Allergy Asthma Rep. 2023 Jan;23(1):1-11. doi: 10.1007/s11882-022-01052-z. Epub 2022 Nov 29. Curr Allergy Asthma Rep. 2023. PMID: 36445652 Free PMC article. Review.
Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names.
Wilkinson I, Hale G. Wilkinson I, et al. MAbs. 2022 Jan-Dec;14(1):2123299. doi: 10.1080/19420862.2022.2123299. MAbs. 2022. PMID: 36109838 Free PMC article.
[Monoclonal antibodies for inflammatory, autoimmune and oncological skin diseases].
Kinberger M, Dobos G, Solimani F. Kinberger M, et al. Dermatologie (Heidelb). 2024 Oct;75(10):762-774. doi: 10.1007/s00105-024-05413-9. Epub 2024 Sep 13. Dermatologie (Heidelb). 2024. PMID: 39271491 Review. German.
SARS-CoV-2 neutralizing antibody bebtelovimab - a systematic scoping review and meta-analysis.
Liew MNY, Kua KP, Lee SWH, Wong KK. Liew MNY, et al. Front Immunol. 2023 Aug 28;14:1100263. doi: 10.3389/fimmu.2023.1100263. eCollection 2023. Front Immunol. 2023. PMID: 37701439 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science